The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 3,935 | 1,531,312 | SH | SOLE | 1,531,312 | 0 | 0 | ||
| AKOUOS INC | COM | 00973J101 | 45,191 | 1,975,984 | SH | SOLE | 1,975,984 | 0 | 0 | ||
| ALLOVIR INC | COM | 019818103 | 12,293 | 447,012 | SH | SOLE | 447,012 | 0 | 0 | ||
| ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 6,516 | 741,290 | SH | SOLE | 741,290 | 0 | 0 | ||
| ANAPTYSBIO INC | COM | 032724106 | 47,544 | 3,223,324 | SH | SOLE | 3,223,324 | 0 | 0 | ||
| APPLIED MOLECULAR TRANS INC | COM | 03824M109 | 36,593 | 1,150,000 | SH | SOLE | 1,150,000 | 0 | 0 | ||
| ARCUS BIOSCIENCES INC | COM | 03969F109 | 31,023 | 1,810,000 | SH | SOLE | 1,810,000 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 293 | 17,800 | SH | Call | SOLE | 17,800 | 0 | 0 | |
| ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 41,895 | 2,548,382 | SH | SOLE | 2,548,382 | 0 | 0 | ||
| ATRECA INC | CL A COM | 04965G109 | 33,901 | 2,426,685 | SH | SOLE | 2,426,685 | 0 | 0 | ||
| AVIDITY BIOSCIENCES INC | COM | 05370A108 | 59,226 | 2,103,950 | SH | SOLE | 2,103,950 | 0 | 0 | ||
| BCTG ACQUISITION CORP | COM | 05492W103 | 8,288 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| CONSTELLATION PHARMCETICLS I | COM | 210373106 | 8,104 | 400,000 | SH | Call | SOLE | 400,000 | 0 | 0 | |
| CYCLERION THERAPEUTICS INC | COM | 23255M105 | 16,673 | 2,742,276 | SH | SOLE | 2,742,276 | 0 | 0 | ||
| DEERFIELD HEALTHCARE TECH AC | UNIT 07/16/2025 | 244413209 | 5,315 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 4,341 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | ||
| EXICURE INC | COM | 30205M101 | 1,781 | 1,017,801 | SH | SOLE | 1,017,801 | 0 | 0 | ||
| FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 1,786 | 379,945 | SH | SOLE | 379,945 | 0 | 0 | ||
| FS DEV CORP | COM CL A | 303020101 | 3,919 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| GERON CORP | COM | 374163103 | 33,462 | 19,230,769 | SH | SOLE | 19,230,769 | 0 | 0 | ||
| GLYCOMIMETICS INC | COM | 38000Q102 | 2,610 | 850,000 | SH | Call | SOLE | 850,000 | 0 | 0 | |
| GLYCOMIMETICS INC | COM | 38000Q102 | 11,436 | 3,725,150 | SH | SOLE | 3,725,150 | 0 | 0 | ||
| GOSSAMER BIO INC | NOTE | 38341PAA0 | 31,008 | 30,000,000 | SH | SOLE | 30,000,000 | 0 | 0 | ||
| HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 4,400 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 1,049 | 25,300 | SH | Call | SOLE | 25,300 | 0 | 0 | |
| IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 4,498 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
| ITEOS THERAPEUTICS INC | COM | 46565G104 | 6,414 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 141,205 | 4,608,529 | SH | SOLE | 4,608,529 | 0 | 0 | ||
| KYMERA THERAPEUTICS INC | COM | 501575104 | 3,231 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| LIFESCI ACQUISITION CORP | COM | 53228P109 | 5,958 | 480,505 | SH | SOLE | 480,505 | 0 | 0 | ||
| LIFESCI ACQUISITION CORP | *W EXP 02/14/202 | 53228P109 | 1,860 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| MEIRAGTX HLDGS PLC | COM | G59665102 | 1,255 | 94,819 | SH | SOLE | 94,819 | 0 | 0 | ||
| METACRINE INC | COM | 59101E103 | 3,403 | 333,332 | SH | SOLE | 333,332 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 77,097 | 464,298 | SH | SOLE | 464,298 | 0 | 0 | ||
| MORPHIC HLDG INC | COM | 61775R105 | 77,642 | 2,839,884 | SH | SOLE | 2,839,884 | 0 | 0 | ||
| NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 46,355 | 3,862,931 | SH | SOLE | 3,862,931 | 0 | 0 | ||
| NURIX THERAPEUTICS INC | COM | 67080M103 | 41,618 | 1,192,156 | SH | SOLE | 1,192,156 | 0 | 0 | ||
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | 66,082 | 2,642,218 | SH | SOLE | 2,642,218 | 0 | 0 | ||
| PANACEA ACQUISITION CORP | UNIT 99/99/9999 | 698102209 | 4,680 | 390,000 | SH | SOLE | 390,000 | 0 | 0 | ||
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 1,775 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| PROTHENA CORP PLC | SHS | G72800108 | 94,172 | 9,426,640 | SH | SOLE | 9,426,640 | 0 | 0 | ||
| RELAY THERAPEUTICS INC | COM | 75943R102 | 136,316 | 3,200,649 | SH | SOLE | 3,200,649 | 0 | 0 | ||
| REPARE THERAPEUTICS INC | COM | 760273102 | 1,539 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| ROYALTY PHARMA PLC | SHS CL A | G7709Q104 | 2,104 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| SAVARA INC | COM | 805111101 | 62 | 56,500 | SH | SOLE | 56,500 | 0 | 0 | ||
| SURFACE ONCOLOGY INC | COM | 86877M209 | 22,999 | 3,333,177 | SH | SOLE | 3,333,177 | 0 | 0 | ||
| SUTRO BIOPHARMA INC | COM | 869367102 | 31,292 | 3,113,617 | SH | SOLE | 3,113,617 | 0 | 0 | ||
| UNITY BIOTECHNOLOGY INC | COM | 91381U101 | 1,024 | 296,000 | SH | SOLE | 296,000 | 0 | 0 | ||
| XENCOR INC | COM | 98401F105 | 176,381 | 4,547,072 | SH | SOLE | 4,547,072 | 0 | 0 | ||
| XOMA CORP DEL | COM NEW | 98419J206 | 957 | 50,809 | SH | SOLE | 50,809 | 0 | 0 | ||